Package 31722-580-60

{"route": ["ORAL"], "spl_id": "d6904ba1-cfd4-b9e4-e053-2a95a90a1106", "openfda": {"nui": ["N0000175572", "N0000175445"], "upc": ["0331722579605"], "unii": ["MD6P741W8A"], "rxcui": ["728223", "728225"], "spl_set_id": ["09ec3e79-c0d3-4b8f-80d8-0a854c4ca339"], "pharm_class_epc": ["CCR5 Co-receptor Antagonist [EPC]"], "pharm_class_moa": ["Chemokine Co-receptor 5 Antagonists [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-580-60)", "package_ndc": "31722-580-60", "marketing_start_date": "20220206"}], "brand_name": "Maraviroc", "product_id": "31722-580_d6904ba1-cfd4-b9e4-e053-2a95a90a1106", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["CCR5 Co-receptor Antagonist [EPC]", "Chemokine Co-receptor 5 Antagonists [MoA]"], "product_ndc": "31722-580", "generic_name": "Maraviroc", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Maraviroc", "active_ingredients": [{"name": "MARAVIROC", "strength": "300 mg/1"}], "application_number": "ANDA203347", "marketing_category": "ANDA", "marketing_start_date": "20220206", "listing_expiration_date": "20261231"}